Another mechanism reported to enhance cyclin D1/CDK4 pathway activation in Ewing sarcoma is via the EWS/FLI1 fusion protein binding the CCND1 gene promoter resulting in increased expression of cyclin D1 protein [25]. This evidence concerns the gene FLI1 and Ewing sarcoma.